A股異動︱華康潔淨一度跌逾13%,董事長被採取留置措施
華康潔淨(301235.SZ)盤中一度跌逾13%,現跌6.94%報30.03元,總市值32.36億元。華康潔淨公告稱,公司收到控股股東、實際控制人、董事長譚平濤家屬通知,譚平濤被廣東省監察委員會立案調查並採取留置措施。經公司過半數董事一致同意,在譚平濤被留置不能履行董事長、法定代表人職責期間,暫由謝新強代爲履行公司董事長、法定代表人職責,以及代爲履行公司董事會專門委員會委員職責,同時授權謝新強代表公司對外簽署相關文件。代行職責的期限自推舉之日起至譚平濤恢復履行職責或公司選舉產生新任相關職務人員之日止。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.